While CROs are gung-ho on some new technologies to manage trials, they still rely heavily on paper-based systems, a new survey shows. Electronic data capture (EDC), electronic trial master files (eTMF) and clinical trial management systems (CTMS) are increasingly in…
Syneos Health and AiCure Announce Partnership to Optimize Patient Engagement and Trial Success First CRO Partnership to Provide Patient, Trial, and Site-Level AI-Driven Insights
MORRISVILLE, N.C. and NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) — Syneos Health®(Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and AiCure, an AI and advanced data analytics company, today announced a novel strategic partnership to drive faster, smarter trials to…
Pharma to increase spend on digital marketing – report
A third of pharma companies will be spending more than half of their marketing budget on digital channels over the next three years, according to a new report. The Indegene Pharma Marketer 2020 report predicted a shift in spend to…
Indian Govt gives go-ahead for 4 medical device parks
The government has given approval for setting up four medical device parks with a view to support Make in India initiative and provide world-class products at affordable price for treatment. The four parks will be set up in Andhra Pradesh,…
The Continuum of Misconduct: Stopping Unintentional Errors Before They Become Intentional Fraud
We’ve all heard the stories of deliberate data fraud in clinical trials: the investigator who created fictional subjects, the lab technician who duplicated test data, the coordinator who altered records. What makes people think they can get away with it?…
FDA Approves Celgene and Acceleron’s Treatment for Rare Blood Disease
The U.S. Food and Drug Administration (FDA) approved Celgene and Acceleron Pharma’s Reblozyl for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions. The approval marks the first approved treatment in…
In $660 Million Deal, Takeda Offloads Non-Core Assets to Germany’s STADA
Takeda Pharmaceutical will unload a portfolio of over-the-counter and prescription pharmaceutical products to Germany-based STADA Arsneimittel AG for$660 million as the company continues to pare down debt from its $62 billion acquisition of Shire. The portfolio of drugs sold to…
Vifor Pharma Teams with Evotec to Form Joint Venture Focused on Kidney Diseases
Swiss company Vifor Pharma and Germany’s Evotec AG launched a joint venture to focus on the discovery and development of new therapies for kidney diseases. Vifor picks up external R&D capabilities for its own nephrology pipeline and Evotec gains a…
Europe allows Edwards’ Sapien 3 TAVR system in low-risk patients
Dive Brief: Edwards Lifesciences’ Sapien 3 transcatheter heart valve is now allowed for use in Europe in patients at low risk for complications in open heart surgery, the medtech said Wednesday. The CE mark expanding the indication for the Edwards…
Epidermal Display Screens for On-Body Flexible Medical Devices
Researchers from Nanjing University in China have developed a way to place displays on human skin that are flexible, safe, and don’t require a lot of power to run. The technology will certainly have implications for the field of wearable…
